RVL Pharmaceuticals plc Operating Lease, Payments
RVL Pharmaceuticals plc reported Operating Lease, Payments of $1.15 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2023-03-20
- RVL Pharmaceuticals plc operating lease, payments for the quarter ending 2019-12-31 was $153.02K.
- RVL Pharmaceuticals plc operating lease, payments for the quarter ending 2019-09-30 was $634.59K.
- RVL Pharmaceuticals plc operating lease, payments for the quarter ending 2019-06-30 was $643.20K.
- RVL Pharmaceuticals plc operating lease, payments for the quarter ending 2019-03-31 was $599.19K.
- RVL Pharmaceuticals plc operating lease, payments for fiscal 2022 was $1.15M, a 21.99% decline from fiscal 2021.
- RVL Pharmaceuticals plc operating lease, payments for fiscal 2021 was $1.48M, a 9.33% decline from fiscal 2020.
- RVL Pharmaceuticals plc operating lease, payments for fiscal 2020 was $1.63M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $1.15M 10-K · filed 2023-03-20 | ||||
| 2021-12-31 | $1.48M 10-K · filed 2023-03-20 | ||||
| 2020-12-31 | $1.63M 10-K · filed 2022-03-30 | $1.93M 10-K · filed 2021-03-30 | |||
| 2019-12-31 | $153.02K derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $787.61K derived: sum of 2 quarters · filed 2021-09-08 | $1.43M derived: sum of 3 quarters · filed 2021-09-08 | $2.03M 8-K · filed 2021-09-08 | $2.43M 10-K · filed 2020-03-19 |
| 2019-09-30 | $634.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.28M derived: sum of 2 quarters · filed 2019-11-14 | $1.88M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $643.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.24M 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $599.19K 10-Q · filed 2019-05-09 |